Krystal Biotech Inc (NASDAQ:KRYS)
| 56.56 Delayed Data As of 3:59pm ET |  +0.35 / +0.62%Today’s Change | 40.04 Today|||52-Week Range 87.29 | -5.73% Year-to-Date |
Latest KRYS News | Press Releases
No recent news for Krystal Biotech Inc.
Today’s Trading
| Previous close | 56.21 |
| Today’s open | 56.20 |
| Day’s range | 56.01 - 56.68 |
| Volume | 818 |
| Average volume (3 months) | 116,686 |
| Market cap | $1.3B |
Data as of 3:59pm ET, 09/16/2021
Growth & Valuation
| Earnings growth (last year) | -42.64% |
| Earnings growth (this year) | -70.93% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.91 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ENTAEnanta Pharmaceutica... | -0.60 | -1.02% |
| MDGLMadrigal Pharmaceuti... | +0.87 | +1.10% |
| MNKDMannKind Corp | -0.13 | -2.67% |
| KURAKura Oncology Inc | +0.08 | +0.40% |
Data as of 4:10pm ET, 09/16/2021
Financials
| Next reporting date | November 15, 2021 |
| EPS forecast (this quarter) | -$0.74 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$32.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Pittsburgh, Pennsylvania |
Forecasts
